PT - JOURNAL ARTICLE AU - Alexander, Lori ED - Escudier, Bernard TI - A Randomized, Controlled, Double-Blind Phase 3 Study of Bevacizumab/Interferon-α2a vs Placebo/Interferon- α2a as First-line Therapy in Metastatic Renal Cell Carcinoma DP - 2007 Sep 01 TA - MD Conference Express PG - 12--13 VI - 7 IP - 3 4099 - http://mdc.sagepub.com/content/7/3/12.2.short 4100 - http://mdc.sagepub.com/content/7/3/12.2.full AB - The AVOREN trial was conducted to compare interferon alone with interferon plus bevacizumab for the treatment of metastatic renal cell carcinoma (RCC). The findings of the trial represent an important step in the recent advances in the treatment of RCC.